EDN1 and type 2 diabetes mellitus: A clinical study by Usharani et al. (2008) [38] showed that NCB-02 (two capsules containing curcumin 150 mg twice daily) significantly reduced the levels of malondialdehyde, ET-1, IL-6 and TNF[alpha] in type 2 diabetes patients.